BPC-157 for ACL recovery: hype vs. science
This title was summarized by AI from the post below.
11mo
Recently, the parent of a 16-year-old recovering from ACL reconstruction asked me where they should inject BPC-157 into their child’s knee. Not if they should use it, but where. That moment captured something I’m seeing more often. Rising patient interest in peptides like BPC-157 and TB-500 for musculoskeletal recovery, often fueled by online hype. The science? Promising in animals, limited in humans. BPC-157 has demonstrated consistent healing effects in animal models, accelerating repair of tendons, ligaments, and muscles across various delivery methods. It also appears to support angiogenesis and counteract the negative effects of corticosteroids on healing.1 However, despite over two decades of preclinical research, there is a paucity of clinical trials evaluating its use for musculoskeletal injuries in humans, and it remains unapproved for medical use by regulatory bodies.2 Collagen peptides do have human clinical data. A meta-analysis of randomized controlled trials found they can improve tendon structure, strength, and post-exercise recovery when combined with resistance training, though the quality of evidence remains moderate.3 Innovation is exciting, but recommending injectable, unregulated peptides to patients, without clinical validation should give us pause. #ACL #sportsmedicine #innovation 1. Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(1):153-159. 2. Jóźwiak-Bębenista M, Kowalczyk E. Bepecin (BPC 157)—current state of knowledge. Pharmaceuticals. 2023;18(2):185. 3. Bischof K, Moitzi D, Stoop R, et al. Impact of collagen peptide supplementation in combination with resistance training on musculoskeletal health: a systematic review and meta-analysis. Sports Med. 2024;54:2865–2888.
More from this author
Chapter 13: Leading in Complex Systems
Adam C. Cady MHS, ATC, CSCS, PA-C 6mo
Chapter 12: Toxic Leadership, What to Avoid
Adam C. Cady MHS, ATC, CSCS, PA-C 6mo
Chapter 11: Leadership Self-Assessment and Identity
Adam C. Cady MHS, ATC, CSCS, PA-C 7mo
Explore related topics
Explore content categories